MedTrace Logo

Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds

NCT04256824 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2023-09-06

No results posted yet for this study

Summary

Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery

Conditions

  • Surgical Site Infection
  • Surgical Wound
  • Surgical Wound Infection

Interventions

DRUG

coated vicryl plus

Coated Polyglactin 910 with Triclosan (coated vicryl plus)

DRUG

Vicryl

Coated Polyglactin 910 without Triclosan (vicryl)

Sponsors & Collaborators

  • Misr University for Science and Technology

    collaborator OTHER

  • Al Safwa Hospital

    collaborator UNKNOWN

  • Al Zohour Hospital

    collaborator UNKNOWN

  • Al-Menia Univeristy Hospital

    collaborator UNKNOWN

  • MSKMC Univeristy Hospital

    collaborator UNKNOWN

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Emad R Issak, Diploma · ClinAmygate

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-05
Primary Completion
2023-10-10
Completion
2024-01-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04256824 on ClinicalTrials.gov